longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bayer Aktiengesellschaft

BAYZF

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Bayer obtains the opportunity for a Supreme Court hearing to challenge the Roundup herbicide cancer lawsuit

    Wallstreetcn·Jan 16 at 08:43 PM
    BAYZF+0.86%
  • Bayer ADR rose 5%, reaching a new daily high

    Wallstreetcn·Jan 16 at 07:33 PM
    BAYZF+0.86%
  • Bayer: Asundexian achieved primary endpoints in Phase 3 clinical trials

    Wallstreetcn·Nov 23, 2025 at 03:53 PM
    BAYZF+0.86%
  • In the third quarter, Bayer's adjusted EBITDA was €1.51 billion, while the market estimate was €1.29 billion

    Wallstreetcn·Nov 12, 2025 at 06:33 AM
    BAYZF+0.86%
  • On the second day of the China International Import Expo, Meituan Medicine signed contracts with seven multinational pharmaceutical companies

    Wallstreetcn·Nov 6, 2025 at 12:56 PM
    PFE+0.68%GILD+1.40%
  • Bayer reaches a settlement in the polychlorinated biphenyl (PCB) case involving schools in the Seattle area of the United States

    Wallstreetcn·Aug 18, 2025 at 07:14 PM
    BAYZF+0.86%
  • Morgan Stanley, BMW, and Bayer issued Chinese panda bonds, following Hungary's action to finance through panda bonds in July

    Wallstreetcn·Aug 8, 2025 at 02:59 PM
    BMWYYBAYZF+0.86%
  • Bayer's pharmaceutical subsidiary revenue for the second quarter met expectations

    Wallstreetcn·Aug 6, 2025 at 05:31 AM
    BAYZF+0.86%
  • In the first quarter, Bayer's adjusted EBITDA exceeded expectations

    Wallstreetcn·May 13, 2025 at 05:31 AM
    BAYZF+0.86%